| answer text |
<p>Following the United Kingdom National Screening Committee’s (UK NSC’s) meeting
in February 2017, the Government accepted the UK NSC’s recommendation that a population
based screening programme for Group B streptococcal (GBS) carriage should not be offered.
This is because there is insufficient evidence to demonstrate that the benefits to
be gained from screening would outweigh the harms.</p><p> </p><p>As screening for
GBS is not recommended, data as requested is not collected. The Chief Scientific Advisor
has recommended that the National Institute of Health Research should commission a
clinical trial to compare universal screening for GBS against usual-risk based care.
This is to provide better quality evidence to assess the clinical effectiveness, benefits
and harms of a screening programme.</p><p> </p><p>Information on GBS in pregnancy
can be found on the NHS Choices which can be accessed here:</p><p><a href="https://www.nhs.uk/conditions/pregnancy-and-baby/pages/pregnancy-infections.aspx"
target="_blank">https://www.nhs.uk/conditions/pregnancy-and-baby/pages/pregnancy-infections.aspx</a></p>
|
|
